REV-ERBα Mitigates Astrocyte Activation and Protects Dopaminergic Neurons from Damage
Journal of Molecular Neuroscience · 2024
DOI: 10.1007/s12031-024-02264-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, 2024. Verfasst von Xiaoyu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, China. Hauptthemen laut MEDLINE: Astrocytes, Nuclear Receptor Subfamily 1, Group D, Member 1, Dopaminergic Neurons. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Parkinson's disease (PD) is characterized by astrocyte activation and disruptions in circadian rhythm. Within the astrocyte population, two distinct reactive states exist: A1 and A2. A1 astrocytes are associated with neurotoxicity and inflammation, while A2 astrocytes exhibit neuroprotective functions. Our investigation focused on the role of REV-ERBα, a member of the nuclear receptor superfamily and a key regulator of the circadian clock, in astrocyte activation. We observed that REV-ERBα expression in A1 astrocytes was reduced to one-third of its normal level. Notably, activation of REV-ERBα prompted a transformation of astrocytes from A1 to A2. Mechanistically, REV-ERBα inhibition was linked to the classical NF-κB pathway, while it concurrently suppressed the STAT3 pathway. Furthermore, astrocytes with low REV-ERBα expression were associated with dopaminergic neurons apoptosis. Intriguingly, the opposite effect was observed when using a REV-ERBα agonist, which mitigated astrocyte activation and reduced dopaminergic neuron damage by 50%. In summary, our study elucidates the pivotal role of REV-ERBα in modulating astrocyte function and its potential implications in PD pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, China.
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, 215002, China.
- Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, China. ljw323@yeah.net.
- Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, China. dongkaiguo@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Zhi, H., Zhang, Z., Li, J., & Guo, D. (2024). REV-ERBα Mitigates Astrocyte Activation and Protects Dopaminergic Neurons from Damage. Journal of Molecular Neuroscience. https://doi.org/10.1007/s12031-024-02264-w
Vancouver
Wang X, Zhi H, Zhang Z, Li J, Guo D. REV-ERBα Mitigates Astrocyte Activation and Protects Dopaminergic Neurons from Damage. Journal of Molecular Neuroscience. 2024. doi:10.1007/s12031-024-02264-w
BibTeX
@article{Wang2024,
author = {Wang, Xiaoyu and Zhi, Hui and Zhang, Zongqin and Li, Jingwei and Guo, Dongkai},
title = {REV-ERBα Mitigates Astrocyte Activation and Protects Dopaminergic Neurons from Damage},
journal = {Journal of Molecular Neuroscience},
year = {2024},
doi = {10.1007/s12031-024-02264-w}
}
EUVIMED